Tag: CBT > Cannabis Rescheduling: Page 8

Legislation and Regulation

DEA, Attorney General Miss Deadline to Respond to 12 US Senators on Cannabis Rescheduling

The Drug Enforcement Administration continues to keep its process behind closed doors despite a congressional letter demanding transparency.

February 14, 2024

Federal Cannabis Legalization

VP Kamala Harris Touts Changing ‘Federal Marijuana Policy’ in Campaign Video

Many industry stakeholders and advocates pushed back, saying the White House hasn’t changed anything since Biden took office.

February 12, 2024

Cannabis Rescheduling

Congressman Presses DEA For Answers on Ongoing Cannabis Scheduling Review

U.S. Rep. Earl Blumenauer wrote to DEA Administrator Anne Milgram Feb. 8 for further details on the review process, including when the agency might publish its draft rule on the scheduling of cannabis.

February 8, 2024

Cannabis Rescheduling

GOP Candidate Nikki Haley Addresses Federal Cannabis Reform

During a recent CNN Republican Presidential Town Hall, CNN’s Jake Tapper asked GOP candidate Nikki Haley whether or not she would support the FDA's recent recommendation to reclassify cannabis to a Schedule III drug.

February 7, 2024

Cannabis Rescheduling

US Congressman Attempts to Sway DEA From Rescheduling Cannabis

Rep. Andy Harris claims the FDA’s eight-factor analysis on cannabis was “flawed,” leading to a “misguided” recommendation to reschedule.

February 2, 2024

Legislation and Regulation

12 US Senators Say Cannabis Should Be Descheduled, Demand Transparency From DEA

The dozen Democrats requested responses to six questions regarding the DEA’s rescheduling process.

January 30, 2024

Legislation and Regulation

Biden Reaffirms Cannabis Stance During Campaign Stop

The president said he’s kept his promise on reform during a political event at South Carolina’s First-in-the-Nation dinner.

January 29, 2024

Legislation and Regulation

Gillibrand, Nadler Joined by New York Leaders in Calling DEA to Deschedule Cannabis

Seven New York Democrats from all elected levels united with NORML, business leaders and advocates in Harlem to push for full removal.

January 29, 2024

Cannabis Retail Price

Rescheduling, Legalization Prospects Top CBT's Most-Read Articles in January

Here are Cannabis Business Times’ top 10 stories this month.

January 25, 2024

Interviews & Opinion

7 Takeaways From the Feds' Cannabis Rescheduling Recommendation

Attorney Jonathan Havens outlines what stood out for him most after reviewing the 252-page document released by the U.S. Department of Health & Human Services.

January 24, 2024

Cannabis Rescheduling

The Unredacted HHS Docs Spell Out the Feds' Stance on Cannabis. So, What Comes Next?

Attorney Shane Pennington asks the pertinent questions: What do these documents say? What do they mean? What difference do they make?

January 17, 2024

Cannabis Rescheduling

Colorado Attorney General Leads Multistate Effort to Support Cannabis Rescheduling

Attorney General Phil Weiser spearheaded a letter signed by 11 other state attorneys general to encourage the Drug Enforcement Administration to reclassify cannabis as a Schedule III drug under the Controlled Substances Act.

January 16, 2024